Analyst Price Targets — HLN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 10, 2025 9:40 am | Rashad Kawan | Morgan Stanley | $10.20 | $9.10 | TheFly | Haleon downgraded to Equal Weight from Overweight at Morgan Stanley |
| April 8, 2024 7:42 am | Rashad Kawan | Morgan Stanley | $9.15 | $8.29 | StreetInsider | Haleon Plc. (HLN) PT Lowered to $9.15 at Morgan Stanley |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for HLN

Haleon PLC Sponsored ADR (HLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Haleon PLC Sponsored ADR (NYSE: HLN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, four have assigned a buy recommendation and two have

Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB) is unlikely to see a positive catalyst from its first-quarter update, Citi believes, in light of softer trading conditions across key markets, preferring Haleon PLC (LSE:HLN, NYSE:HLN) in the sector. The sector faces pressure from weak US flu data, emerging market pricing unwinding and European promotional pressures, which are expected to weigh on near-term…

Haleon PLC's (LSE:HLN, NYSE:HLN) first-quarter sales at the end of next month come with analysts expecting a subdued start to the year due to a weak cough and cold season. Both Citi and UBS forecast organic sales growth of around 2.2% for the quarter, below consensus, due to a lower incidence of seasonal illness in Europe and North America weighing on respiratory product demand.

Fast Retailing was a top contributor during the quarter, driven by strong execution across its global operations. Alibaba was a detractor during the quarter after the company reported mixed fiscal Q2 results. New positions were established in Sea Limited and Grab Holdings, while the portfolio's position in Atlassian was liquidated.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for HLN.
Senate Trading
No Senate trades found for HLN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
